Hormonotherapy for Incidental Prostatic Carcinoma After Surgery for Benign Prostatic Hyperplasia
As the two standard methods of treatment for incidental carcinoma are a wait-and-see policy and a radical treatment by radiotherapy or surgery, the number of patients treated by hormonotherapy is limited. We report our experience with 27 patients who underwent hormonal manipulation for incidental prostatic carcinoma. We compared their evolution with that of 29 patients whose incidentally discovered carcinoma was primarily untreated.
KeywordsLuteinizing Hormone Benign Prostatic Hyperplasia Lymphoid Leukemia Hormonal Manipulation Retropubic Prostatectomy
Unable to display preview. Download preview PDF.